Keyphrases
Comparative Analysis
100%
Interleukin-2
100%
Brain Tumor
100%
Paracrine
100%
Granulocyte Colony-stimulating Factor (G-CSF)
66%
Interleukin-4 (IL-4)
66%
Tumor Cells
33%
B16F10
33%
Median Survival
33%
Antitumor Activity
33%
Central Nervous System Tumors
33%
Infiltration
33%
Tumor
16%
Day Range
16%
Immunogenic
16%
Eosinophil Infiltration
16%
Histopathological Examination
16%
Anti-tumor Response
16%
Local Delivery
16%
Mechanism of Action
16%
Melanoma Cells
16%
Tumor Invasion
16%
C57BL
16%
Tumor Tissue
16%
B16F10 Cells
16%
CD8+ T Cells
16%
Primary Brain Tumor
16%
Long-term Survivors
16%
T-cell Mediated
16%
Tissue Necrosis
16%
Intracranial Melanoma
16%
Cell-mediated Response
16%
Melanoma Tumor Cells
16%
B16F10 Melanoma Cells
16%
Pharmacology, Toxicology and Pharmaceutical Science
Immunotherapy
100%
Interleukin 2
100%
Experimental Brain Tumor
100%
Neoplasm
66%
Interleukin 4
66%
Granulocyte Macrophage Colony Stimulating Factor
66%
Melanoma
50%
Cytokine
50%
Mouse
50%
Antitumor Activity
33%
Central Nervous System Tumor
33%
Loeffler Pneumonia
16%
C57BL 6 Mouse
16%
CD8 Antigen
16%
Brain Cancer
16%
Tissue Necrosis
16%
Tumor Invasion
16%
Neuroscience
Immunotherapy
100%
Interleukin 2
100%
Brain Tumor
100%
Interleukin 4
66%
Granulocyte Macrophage Colony-Stimulating Factor
66%
Central Nervous System
33%
T Cell
16%
Necrosis
16%
CD8
16%
Veterinary Science and Veterinary Medicine
Protocerebrum
100%
Mouse
100%
Granulocyte Macrophage Colony-Stimulating Factor
100%
Central Nervous System
50%
T Cell
25%